Insider Buying: Privia Health Group, Inc. (NASDAQ:PRVA) Director Acquires $163,700.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Thomas A. Mccarthy bought 10,000 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were bought at an average price of $16.37 per share, for a total transaction of $163,700.00. Following the completion of the transaction, the director now directly owns 52,611 shares of the company’s stock, valued at approximately $861,242.07. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Privia Health Group Trading Up 7.4 %

Shares of Privia Health Group stock opened at $17.31 on Friday. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $29.42. The stock has a 50 day moving average of $18.40 and a 200 day moving average of $20.62. The firm has a market cap of $2.07 billion, a PE ratio of 115.40, a PEG ratio of 2.55 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. The business had revenue of $440.80 million during the quarter, compared to analysts’ expectations of $425.81 million. During the same period last year, the business posted $0.14 earnings per share. The company’s revenue for the quarter was up 21.0% compared to the same quarter last year. As a group, equities research analysts forecast that Privia Health Group, Inc. will post 0.21 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on PRVA. Canaccord Genuity Group lowered their price objective on Privia Health Group from $37.00 to $26.00 and set a “buy” rating on the stock in a research report on Friday, May 10th. Evercore ISI lowered their price target on shares of Privia Health Group from $26.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, February 28th. Stifel Nicolaus dropped their price target on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Truist Financial decreased their price objective on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. Finally, TD Cowen dropped their target price on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a report on Friday, March 1st. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group has a consensus rating of “Moderate Buy” and a consensus target price of $25.08.

Institutional Trading of Privia Health Group

A number of large investors have recently made changes to their positions in the business. Covestor Ltd grew its position in Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock worth $154,000 after acquiring an additional 514 shares in the last quarter. Yousif Capital Management LLC increased its position in shares of Privia Health Group by 1.1% during the 4th quarter. Yousif Capital Management LLC now owns 52,628 shares of the company’s stock valued at $1,212,000 after purchasing an additional 563 shares during the last quarter. New York State Common Retirement Fund increased its position in shares of Privia Health Group by 2.7% during the 3rd quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock valued at $643,000 after purchasing an additional 737 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock valued at $176,000 after buying an additional 756 shares during the period. Finally, Glenmede Trust Co. NA lifted its position in Privia Health Group by 0.9% in the third quarter. Glenmede Trust Co. NA now owns 107,711 shares of the company’s stock worth $2,477,000 after buying an additional 976 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.